JH Beijnen - Concepedia

Author

JH Beijnen

The Netherlands Cancer Institute

Also Known As

JH Beijnen

Publications

474

Citations

H-Index

Concepts

All Affiliations

The Netherlands Cancer Institute Slotervaartziekenhuis Utrecht University

About

JH Beijnen is an author at The Netherlands Cancer Institute specializing in medicine, pharmacology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	206
2	Natural Sciences	1	1	26
3	Biomolecular Engineering	1	1	26
4	Chemical Biology	1	1	26
5	Immunology	1	1	43

JH Beijnen

Publications

298

Citations

H-Index

Page 1

	Year	Citations
Relationship between irreversible alopecia and exposure to cyclophosphamide, thiotepa and carboplatin (CTC) in high-dose chemotherapy ME de Jonge, Otilia Dalesio, ADR Huitema, Bone Marrow Transplantation MedicineMetronomic TherapyPharmacologyIrreversible AlopeciaHigh-dose Chemotherapy	2002	57
Pharmacokinetics and pharmacodynamics of carboplatin administered in a high-dose combination regimen with thiotepa, cyclophosphamide and peripheral stem cell support LJC van Warmerdam, Sjoerd Rodenhuis, Elsken van der Wall, British Journal of Cancer Metronomic TherapyPharmacologyHigh-dose Combination RegimenPharmacotherapyMedicine	1996	46
A phase I study of prolonged continuous infusion of low dose recombinant interleukin-2 in melanoma and renal cell cancer. Part I: Clinical aspects L.T. Vlasveld, EM Rankin, Annemarie Hekman, British Journal of Cancer MedicineMelanomaImmunologyProlonged Continuous InfusionClinical Aspects	1992	43
Survival After Massive Ecstasy Overdose S Ramcharan, P. L. Meenhorst, Jmmb Otten, Journal of Toxicology Clinical Toxicology	1998	40
PK/PD Model of Indisulam and Capecitabine: Interaction Causes Excessive Myelosuppression AS Zandvliet, WS Siegel-Lakhai, JH Beijnen, Clinical Pharmacology & Therapeutics	2007	27
Dual topoisomerase I/II inhibitors R. van Gijn, RRH Lendfers, JHM Schellens, Journal of Oncology Pharmacy Practice Medicinal ChemistryBioorganic ChemistryNuclear EnzymesMedicineNatural Sciences	2000	26
Phase II study of a multi-course high-dose chemotherapy regimen incorporating cyclophosphamide, thiotepa, and carboplatin in stage IV breast cancer JG Schrama, JW Baars, MJ Holtkamp, Bone Marrow Transplantation Breast OncologyMedicinePharmacologyPhase Ii StudyBreast Cancer	2001	18
Efficacy of up-front 5-fluorouracil – epidoxorubicin – cyclophosphamide (FEC) chemotherapy with an increased dose of epidoxorubicin in high-risk breast cancer patients Elsken van der Wall, MJ Holtkamp, JW Baars, British Journal of Cancer Breast OncologyMedicinePharmacologyBreast CancerPharmacotherapy	1996	16
Quantitative Determination of Erlotinib And <i>O</i> -Desmethyl Erlotinib in Human Edta Plasma And Lung Tumor Tissue NAG Lankheet, EE Schaake, Hilde Rosing, Bioanalysis	2012	13
Propofol extravasation in a breast cancer patient EJM Huijbers, JW Baars, P. Schutte, Journal of Oncology Pharmacy Practice	2008	12

Page 1